| Contents - 1 C00-D48 - Neoplasms
- 1.1 (C00-C14) Malignant neoplasms, lip, oral cavity and pharynx
- 1.2 (C15-C26) Malignant neoplasms, digestive organs
- 1.3 (C30-C39) Malignant neoplasms, respiratory system and intrathoracic organs
- 1.4 (C40-C41) Malignant neoplasms, bone and articular cartilage
- 1.5 (C43-C44) Malignant neoplasms, skin
- 1.6 (C45-C49) Malignant neoplasms, connective and soft tissue
- 1.7 (C50-C58) Malignant neoplasms, breast and female genital organs
- 1.8 (C60-C63) Malignant neoplasms, male genital organs
- 1.9 (C64-C68) Malignant neoplasms, urinary organs
- 1.10 (C69-C72) Malignant neoplasms, nervous system
- 1.11 (C73-C75) Malignant neoplasms, endocrine glands and related structures
- 1.12 (C76-C80) Malignant neoplasms, secondary and ill-defined
- 1.13 (C81-C96) Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
- 1.14 (C97) Malignant neoplasms of independent (primary) multiple sites
- 1.15 (D00-D09) In situ neoplasms
- 1.16 (D10-D36) Benign neoplasms
- 1.17 (D37-D48) Neoplasms of uncertain or unknown behaviour
- 2 See also
- 3 References
| [edit] C00-D48 - Neoplasms (Note: ICD-10 and ICD-O topography codes are usually the same, but C42 is used in ICD-O but not ICD-10.)[1] (Alphanumeric subcodes are ILDS.) [edit] (C97) Malignant neoplasms of independent (primary) multiple sites [edit] (D37-D48) Neoplasms of uncertain or unknown behaviour - (D48.) Neoplasm of uncertain or unknown behaviour of other and unspecified sites
[edit] See also [edit] References | Pathology: Medical conditions (Diseases/Disorders/Illness, Syndromes/Sequences, Symptoms/Signs, Injuries, etc.) and ICD codes | | | (A/B, 001-139) | | | (C/D, 140-239 & 280-289) | | | | (E, 240-278) | | | | (F, 290-319) | | | | (G, 320-359) | | | | (H, 360-389) | | | | (I, 390-459) | | | | (J, 460-519) | | | | (K, 520-579) | | | | (L, 680-709) | | | | (M, 710-739) | | | | (N, 580-629) | | | | (O, 630-679) | | | | (P, 760-779) | | | | (Q, 740-759) | | | | (R, 780-799) | | | | (S/T, 800-999) | | | |